
Developer of Intelligent Pelvic Floor Rehabilitation Diagnosis and Treatment System Products

Cell Culture Technology Development and Biopharmaceutical Contract Development and Manufacturing Organization (CDMO) Provider
China Securities News (Reporter Xiu Li Zan) — On July 5, the CSRC announced its approval for the initial public offering of shares on the STAR Market by Shanghai OPM Biosciences Co., Ltd., Medlander Medical Technology Inc., MICURX, and Wuxi DCL Electronics Technology Co., Ltd.